- Home
- Applications
- iran
- gastrointestinal
Show results for
Refine by
Gastrointestinal Product Applications Available In Iran
10 applications found
Acute gastroenteritis and gastritis are characterized by inflammation of the mucus membranes of the gastrointestinal tract, most commonly caused by viral infection, with symptoms including nausea, vomiting, diarrhea and abdominal ...
ByRedHill Biopharma Ltd. based in Tel-Aviv, ISRAEL
Excessive use of boric acid products cause human body boric acid or borate salt intake can lead to poisoning, boric acid salt for the skin, usually a wound or oral, or after long-term exposure can cause symptoms for many times, usually borate poisoning may lead to death of the lowest dose, the baby for 2-3 g, for children of 5-6 g, adult for 15 to 20 g, clinical manifestation, may have gastrointestinal mucosa become red, vomiting, diarrhea, vomit and feces blue-green or the symptom such as ...
ByXi`an Unique Electronic & Chemical Co., Ltd. based in Yanta District, CHINA
Borax or borax (borax) can be absorbed quickly from gastrointestinal tract, serous cavity and damaged skin, so it can be poisoned by internal or local application. ...
ByXi`an Unique Electronic & Chemical Co., Ltd. based in Yanta District, CHINA
A defective gastrointestinal (GI) barrier is associated with multiple conditions of high unmet need, including inflammatory bowel disease, chemotherapy-induced gut injury, food allergies, and celiac disease. ...
ByKallyope Inc. based in New York City, NEW YORK (USA)
The GIA surgical stapler is suitable for thoracic surgery, general surgery, urology, obstetrics, and gynecology, such as lobectomy, gastrointestinal anastomosis, etc. GIA stapling device has larger jaws to help adjust the position, which helps to adjust the position. ...
ByVictor Medical Instruments Co., Ltd based in Changzhou, CHINA
Acute Kidney Injury (AKI) is a well-known complication following surgical procedures. So says the weight of clinical evidence. AKI has negative consequences for patient and healthcare provider, leading to worsened long term prospects and heightened costs of care. ...
ByDeltex Medical Limited based in Chichester, UNITED KINGDOM
Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. PRISM4, a Phase 3 trial, is designed to serve as the second pivotal trial of ...
ByFinch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA)
Stempeucel® can reduce inflammation, which allows the tissues around the fistula tract to ...
ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA
Pharma Industry offers many Applications for our Activated Carbon products. We as one of the leading suppliers of Pharma Grade Activated Carbon produce some of the best Activated Carbon products that are known for their purity and consistent strength. Pharma industry uses Activated Carbon mainly for purification of raw materials and intermediate products that are used in the production of Pharmaceutical products as well as for the purification of the final ...
ByBoyce Carbon based in Coimbatore, INDIA
Seres’ microbiome therapeutics represent a transformative new approach to ...
BySeres Therapeutics, Inc. based in Cambridge, MASSACHUSETTS (USA)